.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Healthtrust
Novartis
Dow
Harvard Business School
Julphar
Farmers Insurance
Cerilliant
Johnson and Johnson
AstraZeneca

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018554

« Back to Dashboard
NDA 018554 describes EULEXIN, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the EULEXIN profile page.

The generic ingredient in EULEXIN is flutamide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flutamide profile page.

Summary for 018554

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 018554

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength125MG
Approval Date:Jan 27, 1989TE:RLD:Yes

Expired Orange Book Patents for NDA: 018554

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Deloitte
Chubb
Federal Trade Commission
UBS
Dow
US Army
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot